BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7827347)

  • 1. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal functional reserve in IDDM patients.
    Sackmann H; Tran-Van T; Tack I; Hanaire-Broutin H; Tauber JP; Ader JL
    Diabetologia; 1998 Jan; 41(1):86-93. PubMed ID: 9498635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of blood pressure intervention on renal function in insulin-dependent diabetes.
    Mogensen CE
    Diabete Metab; 1989; 15(5 Pt 2):343-51. PubMed ID: 2612718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy.
    Lithovius R; Harjutsalo V; Forsblom C; Saraheimo M; Groop PH;
    Diabetes Care; 2014; 37(3):709-17. PubMed ID: 24170765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High blood pressure is a major factor in progression of diabetic nephropathy.
    Parving HH; Hommel E
    J Diabet Complications; 1988; 2(2):92-5. PubMed ID: 2971078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
    Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
    Mogensen CE
    Diabetes; 1990 Jul; 39(7):761-7. PubMed ID: 2191882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes.
    Manto A; Cotroneo P; Marra G; Magnani P; Tilli P; Greco AV; Ghirlanda G
    Kidney Int; 1995 Jan; 47(1):231-5. PubMed ID: 7731151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus.
    Rossing P
    Diabet Med; 1998 Nov; 15(11):900-19. PubMed ID: 9827844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus.
    Mogensen CE; Petersen MM; Hansen KW; Christensen CK
    J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
    Lehmann R; Spinas GA
    Praxis (Bern 1994); 1995 Oct; 84(44):1265-71. PubMed ID: 7491450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment.
    Parving HH; Andersen AR; Smidt UM; Christiansen JS; Oxenbøll B; Svendsen PA
    Diabetes; 1983 May; 32 Suppl 2():83-7. PubMed ID: 6400672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus.
    Nørgaard K; Jensen T; Feldt-Rasmussen B
    Diabetologia; 1993 Jan; 36(1):57-61. PubMed ID: 8436254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P; Zuccalà A; Sturani A
    Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.
    Chiarelli F; Verrotti A; Mohn A; Morgese G
    Ann Med; 1997 Oct; 29(5):439-45. PubMed ID: 9453292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.